Dr. Mark Faber, DO – Gilbert, AZ
Emma Johnson
Updated on July 08, 2026
Predictors of vascular disease in myelodysplastic syndromes
Mark G. Faber David R. Lloyd Abhay Singh Jeffrey Baron Amanda Przespolewski Elizabeth A. Griffiths Eunice S. Wang Swapna Thota, eJHaem, 9/28/2020Current State of Myelodysplastic Syndromes: Standard Treatment Practices and Therapeutic Advances
Mark G Faber, DO; Elizabeth A Griffiths, MD; Swapna Thota, MD, Journal of Clinical Pathways, 7/2019
